Comparison the role of BMI, pathologic stage and hereditary related factors on survival between colon and rectal cancers: Frailty competing risks model
View/ Open
Date
2010Author
Asghari Jafarabadi, M
Hajizadeh, E
Kazemnejad, A
Fatemi, SR
Metadata
Show full item recordAbstract
Background & Objectives: Cholera is always being considered as a public health threat in poor and developing countries. However outbreaks of cholera are not very common in central area of Iran; in 2008 district health authority reported a cluster of diarrhea cases. We investigated this cluster to identify the etiological agent, source of transmission and propose control measures. Methods: We analyzed the data of total of 1219 patients with colorectal cancer who registered between 1 January 2002 to 1 October 2007. Data were analyzed using univariate and multivariate Accelerated Failure Time (AFT) parametric survival model with frailty, utilizing STATA statistical software. Results: In the univariate analysis for age at diagnosis, gender, marital status, race and education level, the survival of patients with colon cancer were approximately between half to one fourth and for BMI, alcohol history, Inflammatory Bowel Disease (IBD), familial history of cancer and the pathologic stage of tumor, the survival of patients with colon cancer were significantly (between 0.12 to 0.56 times) shorter than those patients with rectal cancer. In the multivariate analysis, for age at diagnosis (45-65 years), there was significant difference between colon and rectum cancer. But for BMI, alcohol history, IBD and pathologic stage there were not significant differences. The adjusted survival and 1, 2, 3, 4 and 5 year survival of patients with rectal cancer were better than those with colon cancer. Conclusions: Site-specific evaluation of colon and rectum could give a better perspective of factors affecting these cancers. It may help to design of clinical trials, better diagnosis of diseases and optimal administration of specific treatments.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Exosomes in cancer: small vesicular transporters for cancer progression and metastasis, biomarkers in cancer therapeutics
Abak, A; Abhari, A; Rahimzadeh, S (2018)Cancer progression is a polygenic procedure in which the exosomes can function as substantial roles. Exosomes are tiny, phospholipid bilayer membrane nanovesicles of endocytic derivation with a diameter of 40-100 nm. These ... -
Investigating the effect of trimethyl-chitosan-hyaluronate nanoparticles loaded with anti-STAT-3 and anti-Tim-3 siRNA molecules in 4T1 (breast cancer) and CT26 (colorectal cancer) cancer cells
Karami, Reza (Tabriz University of Medical Sciences, Faculty of Medicine, 2024)Tim-3 has been introduced as an important checkpoint in the immune system in recent years and is known as an immune suppressive factor in the tumor microenvironment. STAT-3 has also been introduced as one of the important ... -
Anti?inflammatory and anti?tumor effects of ?-L-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model
Hosseini, F; Mahdian-Shakib, A; Jadidi-Niaragh, F; Enderami, SE; Mohammadi, H; Hemmatzadeh, M; Mohammed, HA; Anissian, A; Kokhaei, P; Mirshafiey, A; Hassannia, H (2018)Cancer-related inflammation (CRI) is associated with the malignant progression of several cancer types. Targeting these pathways is a novel promising strategy for cancer prevention and treatment. In this present study, we ...